Restoring Immune Balance in Autoimmune and Inflammatory Diseases
Oral Therapies to Rebalance the Immune System for Lasting Patient Benefit
We are a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in inflammatory disease.
Millions of patients remain underserved by existing therapies, forced to live with uncontrolled disease. Symptom management is not enough. There is a clear need for more effective, disease-modifying treatments.
Through precision immunology, we target disease-driving pathways to rebalance immune function and drive sustained disease remission.
We are progressing a pipeline of first- and potentially best-in-class therapeutic candidates designed to deliver transformational outcomes for patients.
Outstanding Foundations
Globally recognized founders and an experienced team with a clear focus: to move beyond alleviating the signs and symptoms of disease to achieve lasting, functional cures for patients with inflammatory diseases
Precision Immunology
We are developing precise, oral small molecule, disease-modifying therapies that modulate disease-driving immune cells to rebalance immune function
Industry Validation
Our strategic collaborations with global biopharmaceutical companies validate our innovation and the global market opportunity for transformational therapies targeting multibillion dollar inflammatory disease indications
Transformational Therapeutics
We are building a broad pipeline of first- and potentially best-in-class oral therapies with the potential to deliver biologic-like efficacy with improved safety and tolerability
From Symptom Control to Lasting, Functional Cure
Despite decades of therapeutic advances, a stark reality faces the millions of patients living with inflammatory disease: moving beyond symptom management remains frustratingly difficult to achieve with current treatment options.
Our novel, oral therapies go further. We are aiming to redefine the future of inflammatory disease by targeting its core drivers to achieve sustained disease remission.